SCHEMBL31295751

SCHEMBL31295751

BrC1=CCOCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2324015 0.84
SCHEMBL16099080 0.65
SCHEMBL15625016 0.65 MAPK1 (0.32)
SCHEMBL719637 0.64
SCHEMBL3875466 0.63
SCHEMBL31295760 0.62
SCHEMBL20387096 0.60
SCHEMBL11515968 0.60 HDAC4 (0.38)
SCHEMBL11513144 0.60 HDAC4 (0.38)
SCHEMBL2454612 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735447-A1 AROMATIC NITROGEN-CONTAINING COMPOUNDS, PREPARATION METHODS AND MEDICINAL USES THEREOF Jiangsu Hengrui Pharmaceuticals Co., Ltd. (CN) 2026-05-06 EP disclosed
WO-2025002413-A1 AROMATIC NITROGEN-CONTAINING COMPOUNDS, PREPARATION METHODS AND MEDICINAL USES THEREOF SHANGHAI HANSOH BIOMEDICAL CO., LTD. (CN) 2025-01-02 WO disclosed
WO-2024255765-A1 NOVEL COMPOUNDS, COMPOSITIONS COMPRISING THE SAME AND USES THEREOF NUPHASE THERAPEUTICS (HANGZHOU) LIMITED., CO. (CN) 2024-12-19 WO disclosed